Physical, psychological and social impact of scleroderma in Europe and Brazil by Maia, Ângela & Leite, Catarina da Silva Correia Pereira
Maia, A., & Leite, C. (2012). Physical, psychological and social impact of scleroderma in 
Europe and Brazil. Rheumatology, 51, S 2, 121-121. doi:10.1080/08870446.2012.707817 
 
 
 
Physical, psychological and social impact of scleroderma in 
Europe and Brazil 
 
Ângela Maia & Catarina Leite 
CIPSI, Escola de Psicologia, Universidade do Minho 
angelam@psi.uminho.pt 
catarinaleite@portugalmail.pt 
 
 
Scleroderma involves several physical changes in visible parts of the body, as face 
and hands. Scleroderma affects body image and is associated with depressive and anxiety 
symptoms and sexual dysfunction. These physical disfiguring changes are in visible and 
important interpersonal contact body parts. Scleroderma symptoms can be painful, such as 
digital ulcers, Raynaud's phenomenon, skin changes, joint contractures and 
gastroesophageal reflux, and the severity of these symptoms is associated with depression. 
This study aims mainly to characterize the most common symptoms of scleroderma, the 
impact felt by patients, assess satisfaction with medical care, psychological symptoms and 
illness perception. 
This study has 563 participants belonging to various European countries and Brazil. 
These participants are mostly woman. The instruments used in this study were the Canadian 
Scleroderma Patient Survey of Health Concerns and Research Priorities and The Brief 
Illness Perception Questionnaire. 
The five most common symptoms reported by patients were: joint pain, fatigue, 
Raynaud's, muscle pain and hardening / tightening skin. Fatigue was the symptom reported 
as having more impact on the daily lives of participants. 
Participants who reported more symptoms, also reported higher impact of symptoms. 
Just under one fifth of the participants had a diagnosis of scleroderma with the first doctor 
consulted. Participants with more years of diagnosis revealed to be more satisfied with the 
medical care they receive.  
Almost a third of participants reported that they do not have access to all medical care due to 
its cost. In sum, almost half the participants showed that scleroderma affects their ability to 
work. 
Regarding depression, 38% of participants have sensitivity for sever depression, and 
younger participants reported more symptoms of depression. Depressive symptoms are 
associated with the impact perceived of symptoms and not with the frequency of symptoms.  
In relation to anxiety, 32% of participants reported symptoms of generalized anxiety and 
participants with worse body image reported more symptoms of anxiety. Participants with 
symptoms of generalized anxiety reported more symptoms of pain. 
The symptoms of social phobia are reported by 30% of the participants. More than half of 
participants reported that they avoid activities which they are the center of attention. 
Participants with social phobia reported worse body image. 
Participants reported a high degree of concern with scleroderma and 84% reported concerns 
with body image due scleroderma.  
 
 
 
